"Traditionally, payers and healthcare organizations have measured and benchmarked quality performance using the Medical Attention for Nephropathy measure, which doesn’t include eGFR and is satisfied ...

Genomic testing can benefit patients with chronic kidney disease (CKD) as more causative genes are identified and evidence for clinical utility is discovered. Genomic testing for treating chronic ...

Despite the fact that albuminuria represents a key risk factor for chronic kidney disease (CKD), even in the absence of reduced filtration, testing for the condition is low among adult patients with ...

Please provide your email address to receive an email when new articles are posted on . 32.2% of Medicare fee-for-service beneficiaries received yearly eGFR and urinary albumin-creatinine ratio ...

AUSTIN, Texas--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, commented today on the 2024 Clinical Practice Guideline for the Evaluation and Management of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A survey conducted by Bayer reveals physicians agree ...

blood test In a large US study, only half of patients with stage 3, 4, and 5 had undergone PTH retesting at 12, 8, and 4.5 months, respectively, after treatment with vitamin D sterols, in line with ...

Millions of people in the UK are needlessly suffering from advanced kidney disease, because of a ‘blind spot’ in current testing methods. The traditional test used by the NHS to identify kidney ...

Echocardiography Decline in rates of cardiac stress testing in Medicare beneficiaries aged 66 years from 2008 to 2012. (HealthDay News) — From 2008 to 2012 there was a decrease in overall rates of ...